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Introduction  
        Bacterial infections can influence the reproductive health by either as a direct infection 
of the reproductive organs or as a hematogenous dissemination of a distant/ generalised 
infection. Bacterial sexually transmitted diseases (STDs) are principally caused by the species 
of Neisseria gonorrhoeae, Treponema pallidum, Haemophilus ducreyi, Gardnerella 
vaginalis,Streptococcus agalactiae, Chlamydia trachomatis, Mycoplasma genitalium, 
Mycoplasmahominis, Ureaplasma urealyticum and Ureaplasma parvum. A number of studies 
focused on the STDs in Hungary in the past 20-30 years, however, the infections caused by 
the intracellular parasite Mycoplasma family have not been studied well. It could have been 
due to several factors, including their extreme sensitivity to environmental factors, difficult 
transport and culturing and the lack of specific serological tests. Because of the recent 
technical developments in sampling, cultivation and antibiotic sensitivity testing, we were 
able to culture mycoplasmas in vitro and perform antibiotic susceptibility testing of 
Mycoplasma and Ureaplasma isolates routinely. Since phenotypical characterization cannot 
distinguish between U. parvum and U. urealyticum and M. genitalium and M. hominis 
species, respectively, and genotyping was not available for us, we used the name U. 
urealyticum for both Ureaplasma species and M. hominis for both Mycoplasma species in the 
thesis. Various species in the class of Mollicutes have been shown to cause colonization and 
disease in the human body; as we mentioned before M. hominis, M. genitalium, U. 
urealyticum and U. parvum are urogenital pathogens. Female urogenital infections and its 
complications include urethritis, salpingitis, pelvic inflammatory disease, chorioamnionitis, 
premature birth, habitual abortion, postpartum sepsis, neonatal pneumonia and sepsis. In male 
patients acute and chronic urethritis, acute and chronic prostatitis, epididymitis, 
epididymoorchitis and oligoasthenospermia should be mentioned. It should be mentioned that 
genital mycoplasmas/ ureaplasmas can be found relatively frequently on the genital mucosa 
of sexually active people without any symptoms.  
In the first part of the thesis, we discuss the incidence and antibiotic sensitivity of U. 
urealyticum cultured from the urogenital samples of sexually active Hungarian individuals 
visiting the outpatient service of the National STD Diagnostic and Therapeutic Center at the 
Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, 
Budapest, Hungary.  
The socioeconomical impact of venereal syphilis is significant. According to the 
Centers for Disease Control and Prevention the syphilis prevalence was approximately 400 
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cases/ 100.000 population in the 1940s, before the antibiotics era. The syphilis prevalence 
then steadily decreased and reached 2.1 cases per 100.000 population in 2000-2001. After 
2001, the number of syphilis cases started to increase to 7.5 cases per 100.000 population by 
2015. The prevalence of syphilis was correlated with sex and sexual behavior (highest among 
men, especially among men sex with men), age (highest prevalence age groups were 20–24 
and 24–29 years). Syphilis prevalence was also different between races and regions. 
Importantly, parallel to the increase of the adult acquired syphilis cases, the congenital 
syphilis cases also increased during the 2000s, reaching 12.4 cases per 100.000 live births at 
2015. The Hungarian epidemiology data show similar trends. In 2012 the number of syphilis 
cases increased by 10% compared to 2011, with more than three times more males than 
females. The highest syphilis prevalence was measured at the age group of 25-29 for males, 
and of 20-24 for females. The regional incidence was the highest in Budapest, and Bács-
Kiskun county at the countryside.  
In the second part of the thesis, we discuss syphilis seropositivity in 241 pregnant 
women of the 33.753 delivering serum samples at the Department of Dermatology, 
Venereology, and Dermatooncology of Semmelweis University, Budapest, Hungary from 
January 1, 2009 through December 31, 2011. We evaluate whether the T. pallidum IgM status 
of the mothers with syphilis indicate a risk of connatal syphilis better than Rapid Plasma 
Reagin (RPR) test, and evaluate the use of IgM immunoblots for the identification of infants 
with congenital syphilis. 
C. trachomatis is an obligate intracellular bacterium with cell tropism to epithelial 
cells of the conjunctiva and the urogenital tract. The bacterium is particularly capable of 
establishing persistent infections and chronic inflammation. The local inflammation could 
lead to tarsus and oviduct fibrosis potentially leading to blindness and infertility. Sexually 
transmitted infections (STIs) caused by the urogenital tract pathogens C. trachomatis serovars 
D-K and L1-L3 are the most frequent STIs in the world. While antiseptics are not part of the 
antichlamydial chemotherapy, they have various intravaginal applications including the 
prevention of postoperative infections before cesarean section, trans-vaginal ultrasoundguided 
ovum pick-up, surgical treatment of HPV generated cervical lesions and other invasive 
procedures, and prevention of early-onset neonatal group B Streptococcus infection. 
 In the third part of the thesis we discuss the measurements of the antichlamydial 
effects of iodine aqueous solution, povidone-iodine, chlorhexidine and borax. These 
antiseptics are being used for the treatment of bacterial vaginosis, but their effect on 
Chlamydia trachomatis infections has not yet been investigated. Bacterial vaginosis is a 
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frequent dysbiosis, where the normal lactobacillus-dominated flora is replaced by an anaerob/ 
aerob polymicrobial flora. Bacterial vaginosis increases the risk of acquiring STIs including 
the frequent C. trachomatis infections. Intravaginal antiseptics are part of the bacterial 
vaginosis treatment, and ideally they should also inhibit the bacterial vaginosis-related STIs. 
Therefore, we tested the antichlamydial activity of four antiseptics: iodine aqueous solution, 
povidone-iodine, chlorhexidine and borax.  
 
Aims  
 
I. to determine the incidence of U. urealyticum/ parvum  infections in sexually active 
Hungarian individuals according to ages.  
II. to examine the age distribution of Ureaplasma-positive patients and the frequency of 
of symptoms.  
III. to determine the antibiotic resistance spectrum of U. urealyticum/ parvum isolated 
from these patients.  
IV. to evaluate the T. pallidum IgM immunoblots for the identification of newborns with 
congenital syphilis compared with RPR, T. pallidum particle agglutination (TPPA), 
and enzyme immunosorbent assay (EIA) tests.  
V. to determine the antichlamydial effects of iodine aqueous solution, povidone-iodine, 
chlorhexidine and borax.   
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Materials and methods   
 
Ureaplasma/ Mycoplasma detection and antibiotic sensitivity 
To study the incidence and antibiotic susceptibility of Hungarian Ureaplasma/ Mycoplasma  
strains 4154 samples, 2114 from female and 2040 from male patients ranging between 15 and 
over 60 years of age, were obtained. For culturing the samples the Mycoplasma Duo kit (Bio- 
Rad, France) was used, with an incubation period of 48 hours, 37oC, 5% CO2. The 
determination of antibiotic sensitivity of the 373 Ureaplasma strains collected during a 
sixyear period was done in U9 medium with SIR Mycoplasma kit (Bio-Rad) under the same 
conditions.  
 
Serological diagnosis of maternal and congenital syphilis 
After prescreening 33.753 serum samples for syphilis serological positivity, we used RPR 
(Omega Diagnostics, UK), T. pallidumparticle agglutination (TPPA) test (Fujirebio Inc., 
Japan), and enzyme immunosorbent assay test (Syphilis II-EIA, BioRad, France) to 
investigate 241 maternal serum samples and 242 serum samples of the babies born to these 
mothers. IgM immunoblots (MAST, UK) were prepared from all the 483 serum samples, but 
the IgM–IgG complex and the maternal IgG were evaluated with Mastsorb (MAST, UK) from 
the infants’ serum. IgG immunoblots (MAST, UK) were prepared from the 241 maternal 
serum samples. One of the infants had symptoms like neurosyphilis; this diagnosis was 
confirmed with Venereal Disease Research Laboratory (VDRL) test (Omega Diagnostics, 
UK) and TPPA in the cerebrospinal fluid. 
 
C. trachomatis propagation and HeLa cell culture 
C. trachomatis serovar D strain (UW-3/CX, ATCC) was used, the strain was propagated and 
partially purified. HeLa 229 cells (ATCC) were incubated in 100 µl of minimal essential 
medium (MEM) with Earle salts supplemented with 10 % heat-inactivated fetal bovine serum.   
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 
MTT assay was performed to characterize the maximum non-toxic concentration of the 
antiseptics on HeLa cells. The average viability (OD 540) of three wells with untreated HeLa 
cells was considered the 100% viability. Viabilities of the treated cells were compared to the 
untreated controls as follows: Cell Viability (%) = (OD 540 of treated cells/ OD 540 of 
untreated cells) x 100.   
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Antiseptics used for C. trachomatis growth inhibition, C. trachomatis infection and DNA 
extraction 
Iodine aqueous solution, povidone-iodine (Betadine, EGIS, Budapest, Hungary), 
chlorhexidine-digluconate (Chlorhexamed, GlaxoSmithKline, Brentford, UK) and borax were 
diluted in sucrose-phosphate-glutamic acid buffer (SPG). Concentration ranges of 100- 
0.78 µg/ml for iodine aqueous solution and borax, 390-3 µg/ml for povidone-iodine and 4- 
0.003 µg/ml for chlorhexidine with 2-fold dilutions were tested. All reagents were purchased 
from SIGMA, St. Louis, MO, USA, unless otherwise indicated.   
 
Direct qPCR monitoring of the effects of the antiseptics on C. trachomatis growth 
DirectqPCR was performed as described before in a Bio-Rad CFX96 real-time system, using 
the SsoFast EvaGreen qPCR Supermix (Bio-Rad) master mix and the C. trachomatispykF 
gene specific primer pairs. The qPCR ended with a melting curve analysis. Student’s t-test has 
been used to compare the statistical differences of Ct values between two experimental 
conditions.  
 
Immunofluorescent monitoring of the effects of the antiseptics on C. trachomatis growth 
C. trachomatis growth was evaluated by immunofluorescent staining. Anti-chlamydia LPS 
antibody labeled with Alexa-647, was used for detection of chlamydial inclusions. 
Fluorescence signals were analyzed with an Axon GenePix Personal 4100A DNA chip 
scanner and GenePix Pro (version 6.1) software (Molecular Devices, USA) using the Cy5 
channel and a 5 µm resolution. Inclusion counts were determined by the ChlamyCount 
software.  
 
Results  
Incidence, age distribution, symptoms and antibiotic resistance of genital  
Ureaplasma strains  
 
Prevalence of Ureaplasma infection 
Former microbiological examinations ruled out the possibility of N. gonorrhoeae and C. 
trachomatis infections in patients involved in this study. 2114 samples were collected from 
female patients. 2047 samples were cervix swabs and 11% of these samples were Ureaplasma 
positive by culture. 59 urethra samples and eight urine samples from females were also 
examined. 7.02% of the urethra specimens were Ureaplasmapositive, while all the urine 
samples were negative. Based on these data it can be stated cervix swabs are the most suitable 
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samples for Ureaplasma culturing in female patients. 2040 samples were collected from male 
patients. The vast majority of these samples were obtained from urethra. 3.01% of the urethra 
samples turned out to be Ureaplasma positive by culture. Only 15 samples were glans swab, 
ejaculatum or urine. None of these were culture positive. Altogether 229 and 61 Ureaplasma 
strains were isolated in the study period from females and males, respectively. The total 
prevalence of Ureaplasma strains in the whole population examined was 6.98%. Subsequent 
study in the next two years slightly modified these tendencies showing an increase in the 
prevalence of Ureaplasma positive patients.  
 
Age distribution and frequency of symptoms in Ureaplasma positive patients 
Ureaplasma positive females and males covered a broad spectrum of ages from less than 16 
to over 60-year old. Ureaplasmapositive females from age 20 increased rapidly reaching a 
plateau at age 26, then gradually decreased from age 36 to the late 60s.The distribution of 
Ureaplasma positive males showed a rather different picture. It increased linearly from age 20 
(5%) reaching a 25% peak at age 30, then linearly decreased to <5% at age 50, followed by a 
small rise between age 51-55, then a decrease to 0% over 60 years of age. 
The ratio of symptom-free persons among Ureaplasma positive individuals was above 40% in 
both sexes. The dominant clinical symptoms in females were vaginal discharge (23.53%), 
genital pruritus (9.19%) and colpitis (11.76%). The dominant clinical symptoms in males 
were urethritis (35.48%), balanitis (13.97%) and urethral discharge (7.52%).  
 
Antibiotic resistance of Ureaplasma strains 
The distribution of antibiotic sensitivity of 373 Ureaplasma urealyticum/ parvum strains 
cultured from genital samples showed that no fully sensitive Ureaplasma strain was found. 
Extremely high incidence of resistance was detected in the Ureaplasma strains against 
erythromycin and clindamycin. However, cross resistance against the two macrolides, the 
older erythromycin and the newer azithromycin existed only in less than 10% of the strains. 
Every fourth strain was resistant to ofloxacin as representative of fluoroquinolons. 
Doxycycline proved to be the most effective agent with 97.32% susceptibility, followed by 
tetracycline (95.9%) and azithromycin (85.79%).   
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Serology of genstational and connatal syphilis  
 
Clinical and serostatus of pregnant syphilis positive women and their children  
Positive syphilis serology was noted in 241 pregnant women out of the 33.753 delivering 
serum samples during a three-year period. 230 mothers had adequate prenatal care. 217 of the 
cared mothers have already been adequatly treated against syphilis before pregnancy, they 
were advised to repeat therapy, according to the Hungarian guidelines. These women had 
RPR titer of 0-1:16, results of TPPA, EIA and IgG immunoblot tests were also positive, but 
IgM immunoblots results were negative. Children of these mothers had RPR titers of 0-1:8, 
equal or less than their mothers.  All TPPA and EIA reactions were positive in these children, 
only IgM immunoblots were negative. These infants were uninfected, without any symptoms 
of connatal syphilis at birth. Eleven women, having received inadequate prenatal care, 
classified as latent syphilis patients, were first found to have reactive test results for syphilis at 
delivery. Seven mothers had the diagnosis of syphilis latens tarda, with negative RPR and 
IgM immunoblot results, but with positive TPPA, EIA and IgG immunoblot tests. At delivery 
the RPR test results of their infants were negative, however, TPPA and EIA were positive. 
None of these children had a positive IgM immunoblot result.The other four mothers, had the 
syphilis latens recens diagnosis at delivery, with an RPR titer at least 1:2 to a maximum of 
1:256. TPPA, EIA and IgG immunoblot tests were all positive. One mother with an RPR titer 
of 1:64 has already had IgM negative immunoblot result. Her baby had the same serological 
results and had no clinical symptoms of syphilis, after adequate treatment the follow-up 
examinations and serological testing at 0, 3, 6, 9 and 12 months confirmed the absence of 
connatal syphilis infection. The last three women were found to have positive IgM results 
together with the other reactive syphilis tests at delivery. Remarkably, the first of them, an 
intravenous drug user, has had an RPR titer only of 1:2, but one of her twin sons has died 
immediately after birth. The RPR titer of this „A” infant was 1:8.  RPR titer of „B” infant was 
1:2, his treponemal tests, including IgM immunoblot, were all positive. The second 
motherchild pair had the same RPR titer of 1:256, all treponemal tests, including IgM 
immunoblot were positive in both of them, but the infant had no symptoms of connatal 
syphilis. The last mother had an RPR titer of 1:64, TPPA, EIA and IgG, IgM immunoblots 
were positive. The premature daughter had RPR titer of 1:64, positive results of TPPA, EIA 
and IgM immunoblot. Prematurity was the only non-specific clinical manifestation of 
connatal syphilis in this case.   
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Impact of antiseptics on C. trachomatis growth  
Cell viability of HeLa cells incubated with antiseptics 
We tested the long term impact of the antiseptics on the viability of the HeLa human cervical 
epithelial cells. HeLa cell viability was determined by MTT assay after 48 h incubation. The 
maximum non-toxic concentrations were 390 μg/ml, 200 μg/ml, 2 μg/ml and 25 μg/ml for 
povidon-iodine, iodine aqueous solution, chlorhexidine and borax, respectively. The 
maximum non-toxic concentration for borax was 25 μg/ml, but the cell viability for borax 
reached 80% at 400 μg/ml.  
 
Direct qPCR measurement of the impact of antiseptics on C. trachomatis growth 
The direct qPCR method was used to determine the antichlamydial activity of antiseptics. 
HeLa cells were infected with C. trachomatis at multiplicity of infection 8 (MOI 8) after 
preincubation (37 oC, 1 h) with serial 1:2 dilutions of povidone-iodine, chlorhexidine, iodine 
aqueous solution and borax starting with the maximum non-toxic concentrations. The 
antiseptics’ MICs were calculated as it was described before. Briefly, the chlamydial DNA 
concentrations (threshold cycle (Ct) values) measured in the three parallel wells of a given 
antiseptic concentration were compared with the Ct values measured in the three parallel 
wells of the highest antiseptic concentration (we considered it as the inoculum) using 
Student's t-test. The lowest antiseptic concentration, where the Ct values did not change 
significantly compared with the inoculum was considered the MIC value. The MIC value of 
povidone-iodine was 97 μg/ml, the MIC value of chlorhexidine was approximately 4 μg/ml. 
The iodine aqueous solution and the borax did not show antichlamydial activity in the tested 
concentration range.   
 
Estimation of the qPCR inhibitory activity of the antiseptics 
Since the growth related chlamydial DNA synthesis was measured by a qPCR method, we 
tested whether the applied antiseptics had a direct inhibitory impact on the qPCR. This effect 
could appear as a false-positive antichlamydial activity. The Ct levels of the povidone-iodine, 
chlorhexidine, iodine aqueous solution and borax mixtures were only 1.33, 0.79, 0.85 and  
1.28cycles higher than the untreated C. trachomatis infected cell lysate’s, therefore the 
observed antichlamydial effect of the antiseptics were not due to the inhibition of the qPCR. 
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ChlamyCount immunofluorescent measurement of the impact of antiseptics on C. 
trachomatis growth 
To validate the qPCR results with an independent chamber slide infection method, we 
performed C. trachomatis infections (MOI 8) in the presence of the antiseptics with the 
highest concentrations used for qPCR. ChlamyCount inclusion number data showed that the 
povidone-iodine and chlorhexidine treatment decreased the chlamydial inclusion number 
approximately 94 % and 94 %, respectively, while the iodine aqueous solution and borax 
decreased the number of chlamydial inclusions by 13 % and 43 %, respectively.  
 
Discussion 
Incidence and antibiotic susceptibility of U. urealyticum/parvum 
Ureaplasmas are common bacteria of the human urogenital tract. Screening of 
asymptomatic men showed that 11% of them were colonized. Ureaplasma was detected in 
children (5%), in sexually inactive women during reproductive age (40%), in sexually active 
women (60-80%) and also in postmenopausal women (25%). In pregnancy the detection rate 
can be as high as 82% and 24% in the puerperium. Based on our results we can state that U. 
urealyticum/ parvum  strains have high prevalence in both sexes in the Hungarian population. 
We were able to detect U. urealyticum/ parvum in all sexually active age groups; the highest 
number of isolates were from age group of 21-40 years in both men and women. Concering 
the symptoms. The ratio of symptom-free carrierswas above 40% in both sexes. Comparing 
our resistance results with those published in international journals, we found similar 
tendencies regarding certain antibiotics such as macrolides, clindamycin and tetracycline, as 
well as the outstandingly high erythromycin and clindamycin resistance and cross-resistance, 
while we found deviations in cases regarding fluoroquinolone resistance. Regarding 
erythromycin and clindamycin resistance, the examination method we applied showed only 
constitutive cross-resistance. According to literature data, azithromycin and josamycin are the 
most effective antibiotics against Ureaplasma, but resistant strains have already been isolated. 
Our data showed, that azithromycin was effective against Hungarian Ureaplasma strains. In 
our study fluoroquinolons were represented by ofloxacin with 25.2% resistance. The 
Hungarian situation is significantly more favourable than those in other countries. 
Tetracycline was effective in 95.9% on Hungarian Ureaplasma strains. Doxycycline seems to 
be the drug of first choice in case of Ureaplasmainfections with only 2.41% resistance. In 
case of pregnancy, infancy and allergy the medication to be chosen is azithromycin. In case of 
suspected U. urealyticum/ parvuminfection we highly recommend to test the antibiotic 
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resistance after the first unsuccessful antibiotic therapy. The most up-to-date procedure is, 
however, to perform antibiotic sensitivity test prior to commencing therapy. 
 
Serological identification of gestational and congenital syphilis in the Hungarian 
population 
Globally, nearly two million pregnant women are infected with T. pallidum each year. 
Approximately 50% of women with untreated syphilis have been transmitting the infection to 
their newborn child, resulting in profound adverse outcomes including an estimated 440.000 
perinatal deaths each year. Since 1994, almost every year a congenital syphilis case has been 
observed in Hungary. In 2007 and 2008, one and two cases were observed, respectively. RPR 
test used for screening has the advantage of being inexpensive, widely available, and usable 
for determination of treatment efficacy. Limitations of this non-treponemal test include the 
lack of sensitivity in primary and late syphilis and the possibility of a prozone reaction or 
false-positive results. Treponemal tests like EIA or TPPA are technically more difficult to 
perform and more expensive, but they remain reactive for years with or without treatment. 
Several antigens that elicit high antibody titers during T. pallidum infection and are not 
crossreactive with serum from patients with other common spirochetal diseases have been 
identified. TPPA and EIA tests were developed using these recombinant antigens.   
From the 241 mothers with positive syphilis screening tests, 217 were successfully 
treated before pregnancy. The next 13 pregnant women diagnosed with syphilis during 
pregnancy opted for treatment. The remaining 11 mothers were diagnosed with syphilis only 
at delivery. All four connatal syphilis cases were from mothers without undergoing prenatal 
care and syphilis screening. The success rate for mother-to-child transmission intervention 
(number of successful interventions/ number of syphilis positive women who received 
intervention) was 100% in our cases. Rawstron et al. determined maternal IgM status to be 
better indicator for a risk of connatal syphilis than a maternal RPR titer ≥1:16. However, they 
described that neither a titer ≥1:16 nor TP IgM reactivity identified all mothers who delivered 
infected infants; they found babies with congenital syphilis whose mothers had negative TP  
IgM and RPR titers ≤1:8. In our study, the mother of the twins with connatal syphilis had only 
an RPR titer of 1:2. None of the mothers of the infected children was IgM negative in our 
cases. The infant of the untreated mother, who had an RPR titer of 1:64, but was negative for 
IgM, was uninfected. Infected infants can produce IgM in utero after 3 months. Previous 
studies using either ELISA or T. pallidum IgM Western-Blot have similarly found that IgM 
antibodies cannot be detected in all babies with congenital syphilis. Serodiagnosis of 
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congenital syphilis is difficult because of the transfer of the IgG antibodies from mother to 
fetus. Fetus produces IgM antibodies (rheumatoid factor= RF), against maternal IgG. IgG–RF 
complex reacts in IgM immunoblot, or maternal IgG compete with fetal IgM for the 
Agbinding position, resulting in false-positive or false-negative tests, respectively. We found 
reactivity to antigens of 45, 17, and 15 kDa only in one case. Our observations confirm that 
antenatal syphilis screening with the parallel use of treponemal (EIA, TPPA) and 
nontreponemal (RPR) tests facilitates detection and treatment of syphilis during pregnancy. 
Successful treatment offsets vertical transmission. The use of IgM immunoblot examination 
allows the identification and treatment of high-risk newborns.  
 
Measurement of the antimicrobial activities of various antiseptics against C. trachomatis 
We tested the cytotoxic- and antichlamydial effects of various antiseptics that can be 
used intravaginally. The cytotoxicity tests revealed that iodine and borax did not influence the 
viability of the HeLa cervical epithelial cell lines at the tested concentration range, while the 
povidone-iodine and chlorhexidine showed a concntration-dependent toxicity after 48 hours 
of incubation, the time of the developmental cycle of C. trachomatis. In the case of these two 
antiseptics we used the maximum non-toxic concentration for further tests of antichlamydial 
capacity. We used a preincubation of the chlamydial elemntary bodies with the antiseptics, to 
mimic the effect of these compounds on the extracellular infectious form of C. trachomatis. 
However it cannot be excluded that these antiseptics can be transported into the host cells and 
may have an effect on the intracellular development of the bacterium. Further studies needed 
to measure the intracellular effects of the antiseptics.   
Instead of measuring the chlamydial growth inhibition by immunofluorescent staining 
of the so-called inclusions of C. trachomatis, we used the recently developed qPCR based 
chlamydial DNA accumulation measurement as a readout of chlamydial replication. Our 
qPCR data showed that the chlorhexidine and povidone-iodine had an antichlamydial effect, 
while the iodine aqueous solution and borax did not possess any antichlamydial activity in the 
tested concentration range. Chlorhexidine had the lowest antichlamydila MIC, but the MIC 
was close to the maximum non-toxic concentration, therefore its therapeutic index was low. 
Our data indicates that chlorhexidine could be an effective antichlamydial agent in vivo, but 
may be applied as a short term rinsing, rather than as a long-term vaginal gel. On the other 
hand, the povidone-iodine had a MIC of 97 μg/ml, while its maximum non-toxic 
concentration was 390 μg/ml, suggesting that this antiseptic can be applied long-term 
intravaginally.   
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Also, to validate the qPCR-based growth measurements, we used the 
immunofluorescence based ChlamyCount growth measurement system. ChlamyCount data 
validated the qPCR measurements in the case of povidone-iodine and chlorhexidine, although 
the extent of detected growth reduction was lower than that determined by qPCR. The reason 
could be that the dynamic range of our immunofluorescent ChlamyCount method was about 2 
log10, while the qPCR method’s dynamic range was ~5 log10. Different from the qPCR results, 
the ChlamyCount method also showed a limited chlamydial growth inhibition in the case of 
iodine aqueous solution and borax. The fact that the chlamydial DNA synthesis remained 
constant after the application of these latter two compounds but the inclusion numbers slightly 
decreased, might indicate that small portion of the iodine aqueous solution and borax treated 
chlamydial EBs become persistent, maintaining the chlamydial DNA synthesis, but formed 
smaller/ less intense inclusions that was not detected by the ChlamyCount method.  
Altogether, our results showed, that povidone-iodine had the widest antichlamydial 
therapeutic index and could maintain an antichlamydial effect when used intravaginally. Since 
C. trachomatis infection could be linked to bacterial vaginosis, povidone-iodine may treat/ 
limit these two clinical entities at the same time.  
 
New results of the thesis  
 
1. We showed that the prevalence of U. urealyticum/ parvum species is high in sexually 
active female and male populations in Hungary.  
 
2. We revealed that in the Hungarian population the age distribution was different 
between the Ureaplasma positive females and males.  
 
3. We performed a large-scale antibiotic resitance screen of Ureaplasma isolates in 
Hungary. We showed that the erythromycin and clindamycin resistances were 
extremely high, but the cross-resistance between the two macrolides, the older 
erythromycin and the newer azithromycin was infrequent. Every fourth strain was 
resistant to ofloxacin as representative of fluoroquinolons. Doxycycline proved to be 
the most effective agent with 97.3% susceptibility, followed by tetracycline and 
azithromycin.Because of the extremely high ratio of erythromycin and clindamycin 
resistant strains, the present guideline to treat ureaplasma infection have to be change 
15 
 
by replacing erythromycin with azithromycin. Moreover, administering erythromycin 
has the danger to further  select the resistant strains. 
 
4. We studied the incidence of gestational and connatal syphilis in the Hungarian 
population. We concluded, that maternal IgM immunoblot results identify mothers at 
risk of delivering babies with connatal syphilis better than the height of maternal RPR 
titer. Our data of Hungarian newborns, supports the previous results in connatal 
syphilis serology. In newborns, IgM test which depends on the infant’s response has 
more specificity in diagnosing connatal syphilis than IgG that can transfer across the 
placenta.  
 
5. We tested the antichlamydial effect of four vaginal antiseptics. We showed that 
povidone-iodine and chlorhexidine had a marked antichlamydial activity when applied 
at concentrations that was not toxic to the host epithelial cells. The therapeutical index 
of povidone-iodine was higher than that of chlorhexidine, indicating a higher clinical 
safety in vivo.   
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